Research
Metabolic adaptation
Insulin users incur at least double the one-year T2D-HE compared to non-users within each BMI category.
Insulin therapy significantly increases healthcare costs for patients with type 2 diabetes.
StrongSupportsmedium confidence
Within each BMI category, insulin users' one‐year T2D‐HE was at least double that of non‐users.
Why this rating
Based on a large retrospective analysis of patient data.
Source
Body mass index and insulin use as identifiers of high‐cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data
Stephen S. Johnston et al. · Diabetes Obesity and Metabolism · 2019
cohort · n=13026Cited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →